FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Keystone Industries Henry Schein Recall

Henry Schein, Benzo-Jel, Topical Anesthetic Gel, 20% Benzocaine, 1 fl

Keystone Industries · Gibbstown, NJ

Risk level
Class II
Reported by FDA
Dec 25, 2024
Recall ID
D-0148-2025
Check your lot numberHow we source this data

Summary

Keystone Industries recalled Henry Schein starting Nov 14, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0148-2025 on Dec 25, 2024. Reason: CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers. Status: Terminated.

Why it was recalled

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

Product description

Henry Schein, Benzo-Jel, Topical Anesthetic Gel, 20% Benzocaine, 1 fl. oz. (29.6 mL), Distributed by Henry Schein, Melville, NY 11747, For Professional Use Only,

Lot numbers, UPCs & expiration codes

Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-43619

Where it was sold

Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0148-2025
Classification
Class II
Status
Terminated
Recall initiated
Nov 14, 2024
FDA report date
Dec 25, 2024
Recall type
Voluntary: Firm initiated
Recalling firm
Keystone Industries

Original FDA data

Every field from FDA enforcement report D-0148-2025, exactly as published.

Show all FDA fields
City
Gibbstown
State
NJ
Status
Terminated
Country
United States
Event ID
95854
Address
480 S Democrat Rd
Code information
Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-43619
Postal code
08027-1239
Report date
Dec 25, 2024
Product type
Drugs
Recall number
D-0148-2025
Classification
Class II
Recalling firm
Keystone Industries
Termination date
Apr 23, 2026
Reason for recall
CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Henry Schein, Benzo-Jel, Topical Anesthetic Gel, 20% Benzocaine, 1 fl. oz. (29.6 mL), Distributed by Henry Schein, Melville, NY 11747, For Professional Use Only,
Distribution pattern
Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.
Recall initiation date
Nov 14, 2024
Initial firm notification
E-Mail
Center classification date
Dec 13, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0148-2025, published Dec 25, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls